Septerna (SEPN) Current Assets (2023 - 2026)
Septerna (SEPN) recorded quarterly Current Assets of $368.1 million in Q1 2026, down 10.44% quarter-over-quarter from $411.0 million in Q4 2025, and up 7.47% on a YoY basis from $342.5 million in Q1 2025.
Septerna (SEPN) Current Assets (2023 - 2026) Analysis & Trends
Septerna's Current Assets history runs 4 years deep, the most recent figure standing at $368.1 million for Q1 2026.
- In Q1 2026, Current Assets rose 7.47% year-over-year to $368.1 million; the TTM figure through Mar 2026 stood at $368.1 million (up 7.47% YoY), while the FY2025 annual figure was $411.0 million, up 15.17% from the prior year.
- Current Assets was $368.1 million for Q1 2026 at Septerna, down from $411.0 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $491.7 million in Q3 2025 to a low of $112.7 million in Q4 2023.
- Historically, Current Assets has averaged $318.8 million across 4 years, with a median of $349.6 million in 2024.
- The sharpest annual moves came in 2025 and 2026: Current Assets jumped 268.55% in 2025, then climbed 7.47% in 2026.
- A 4-year view of Current Assets shows it stood at $112.7 million in 2023, then soared by 216.68% to $356.8 million in 2024, then grew by 15.17% to $411.0 million in 2025, then dropped by 10.44% to $368.1 million in 2026.
- The last three Current Assets figures came in at $368.1 million (Q1 2026), $411.0 million (Q4 2025), and $491.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 3.59 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 600.85 Mn |
| 10 | Septerna | 1.62 Bn | 1.62 Bn | - | 368.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 368.06 Mn |
| Dec 31, 2025 | 410.96 Mn |
| Sep 30, 2025 | 491.68 Mn |
| Jun 30, 2025 | 334.14 Mn |
| Mar 31, 2025 | 342.47 Mn |
| Dec 31, 2024 | 356.82 Mn |
| Sep 30, 2024 | 133.41 Mn |
| Dec 31, 2023 | 112.68 Mn |